Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Screening Workshop

Rathnam Chaguturu's Biography



Rathnam Chaguturu, Founder and CEO/Senior Director, SRI International

Rathnam Chaguturu is the Founder & CEO of iDDPartners, a nonprofit think-tank focused on pharmaceutical innovation. He has more than thirty-five years of experience in academia and industry, managing new lead discovery projects and forging collaborative partnerships with academia, disease foundations, nonprofits, and government agencies.. He is the Founding President of the International Chemical Biology Society, a Founding Member of the Society for Biomolecular Sciences, and Editor-in-Chief of the journal, Combinatorial Chemistry and High Throughput Screening. He serves on several editorial- and scientific advisory boards, recipient of several awards, and is a sought-after speaker at major national and international conferences, passionately advocating the virtues of collaborative partnerships in addressing the pharmaceutical innovation crisis. ‘Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships,’ edited by Rathnam with the Foreword by Ferid Murad, the 1998 Nobel Prize winner in Medicine, has just been published by Wiley.

Rathnam Chaguturu Image

Open Innovation-based Public-Private Partnerships: Promise or Panacea for Precompetitive Drug Discovery Initiatives

Friday, 21 September 2012 at 08:00

Add to Calendar ▼2012-09-21 14:30:002012-09-21 15:30:00Europe/LondonExpert panel discussion on “Should academia be doing drug discovery?”Academic Screening Workshop in Baltimore, USABaltimore, USASELECTBIOenquiries@selectbiosciences.com

Expert panel discussion on “Should academia be doing drug discovery?”

Friday, 21 September 2012 at 14:30

Add to Calendar ▼2012-09-21 14:30:002012-09-21 15:30:00Europe/LondonExpert panel discussion on “Should academia be doing drug discovery?”Academic Screening Workshop in Baltimore, USABaltimore, USASELECTBIOenquiries@selectbiosciences.com

Panelists: Hakim Djaballah, MSKCC; Jim Inglese, NIH; Robert Zivin, Johnson & Johnson; Mel Reichman, LIMR; Ricardo Macarron, GSK; David Epstein, OSI Pharmaceuticals; Mohan Thiruvazhi, GVK Bio; Peter Brown, University of Toronto; Thomas Chung, Burnham; Terry Riss, Promega


Add to Calendar ▼2012-09-20 00:00:002012-09-21 00:00:00Europe/LondonAcademic Screening WorkshopAcademic Screening Workshop in Baltimore, USABaltimore, USASELECTBIOenquiries@selectbiosciences.com